Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 2/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | JAK2 | O60674 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | TOP1 | P11387 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13828284 | 0.89 | HSD17B10 (0.69) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL13827370 | 0.89 | HSD17B10 (0.69) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL13827371 | 0.89 | HSD17B10 (0.69) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL2337247 | 0.88 | KDM4E (0.66) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL1914132 | 0.85 | SLC6A3 (0.72) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL28263594 | 0.85 | HSD17B10 (0.72) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL113040 | 0.85 | SLC6A3 (0.71) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL30505635 | 0.85 | SLC6A3 (0.71) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL1979275 | 0.85 | SLC6A3 (0.71) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA | |
| SCHEMBL28549086 | 0.85 | SLC6A3 (0.57) | SLC6A3KMT2AMAPTSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116490643-A | System and method for carbon dioxide reactor control | 十二益公司 | 2023-07-25 | — | — | CN | disclosed |
| EP-3104835-B1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2019-02-13 | — | — | EP | disclosed |
| US-9877484-B2 | Pulvurent effervescent topical treatment composition | RECKITT BENCKISER LLC (US) | 2018-01-30 | — | — | US | disclosed |
| US-20170006874-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2017-01-12 | — | — | US | disclosed |
| EP-3104835-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | Reckitt Benckiser LLC (US) | 2016-12-21 | — | — | EP | disclosed |
| CN-103402486-B | Two-part cosmetic product | 莱雅公司 | 2016-11-23 | — | — | CN | disclosed |
| WO-2015121659-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | RECKITT BENCKISER LLC (US) | 2015-08-20 | — | — | WO | disclosed |
| CN-103402486-A | Two-part cosmetic product | OREAL | 2013-11-20 | — | — | CN | disclosed |
| WO-2003106688-A1 | GLUCOSYLTRANSFERASES WHICH CLUCOSYLATE SALICYLIC ACID | THE UNIVERSITY OF YORK (GB) | 2003-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170006874-A1 | PULVURENT EFFERVESCENT TOPICAL TREATMENT COMPOSITION | SOST, FPR2, SHH | SLC6A3 4679/4885KMT2A 3873/4885MAPT 1882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.